The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1
Longevity medicine mainstreaming: tesamorelin fits squarely into the longevity conversation, where visceral fat reduction and cognitive preservation are both high-priority outcomes
For now they sit in the category of promising but unproven
Understanding why GLP-1 hair loss occurs and what treatment options are available can help you stay on track with your weight-loss goals while protecting the health and fullness of your hair
FDA Reporting You or your healthcare provider can report suspected adverse reactions to the FDAs MedWatch Program at 1-800-FDA-1088 or online at www.fda.gov/medwatch
Even though the Costco + Sesame program doesn't include the cost of the drugs themselves, a subscription to the program might make weight-loss drugs more accessible and more affordable